Home » Topics » BioWorld Science

BioWorld Science
RSS

Gilead Sciences identifies new LPAR1 antagonists

Dec. 23, 2021

Autobahn Therapeutics divulges new thyromimetic compounds

Dec. 23, 2021

Topspin Therapeutics patents TMPRSS2 inhibitors

Dec. 23, 2021

SL-010110 inhibits gluconeogenesis and improves glucose homeostasis in diabetic mice

Dec. 23, 2021

Biomimetic synthesis of compounds from naturally abundant arglabin

Dec. 23, 2021

LAIR-1-targeting antibody NC-525 potentially effective against AML

Dec. 23, 2021

Novel pleuromutilin derivatives with promising anti-MRSA activity

Dec. 23, 2021

Human mAbs prove a safe alternative to tetanus Ig for tetanus prevention and treatment in mice

Dec. 23, 2021

SOCS1 is a major intracellular negative checkpoint of adoptive T-cell responses

Dec. 23, 2021

Noncanonical NLRC4 inflammasome mechanism offers new targets for sterile inflammatory disorders

Dec. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...